Effect of Using Virtual Glasses on Anxiety, Pain and Comfort During Uterine Tonus Assessment (Uterine Tone)

April 16, 2026 updated by: Mevhibe Coban, Inonu University

This randomized controlled experimental study aimed to determine the effect of using virtual glasses during uterine tone assessment on anxiety, pain and comfort. The hypotheses of this study were determined as follows:

H1-a: Using virtual reality glasses during uterine tone assessment affects anxiety.

H1-b: Using virtual reality glasses during uterine tone assessment affects pain.

H1-c: Using virtual reality glasses during uterine tone assessment affects comfort.

Study Overview

Detailed Description

Data collection tools will be collected from women who gave birth in the Maternity Ward of Malatya Education and Research Hospital between February 2024 and February 2025 and who agreed to participate in the study, using the face-to-face interview method on weekdays by the researchers. Data will be collected in two stages. The application time of the data collection tools is planned to be completed in approximately 20 minutes as pre-test and post-test. Before the women in the experimental group are applied with SG glasses, the Personal Information Form, State Anxiety Scale (SAS), Visual Analog Scale (VAS) and General Comfort Scale (GCS) will be applied and pre-test data will be collected. Then, these women will watch videos with nature scenes using SG glasses during the uterine tone assessment. After the uterine tone assessment process is completed, the pregnant women in the experimental group will be applied the State Anxiety Scale (SAS), Visual Analog Scale (VAS) and General Comfort Scale (GCS) again and the post-test data will be collected and the data collection process will be completed. Before the uterine tone assessment, the State Anxiety Scale (SAS), Visual Analog Scale (VAS) and General Comfort Scale (GCS) will be applied to the women in the control group and pre-test data will be collected. No intervention will be applied to these women during the uterine tone assessment process. After the uterine tone assessment process is completed, the State Anxiety Scale (SAS), Visual Analog Scale (VAS) and General Comfort Scale (GCS) will be applied to the pregnant women in the control group again and post-test data will be collected, and the data collection process will be completed. The pre-natal hemoglobin value and the 6th hour post-natal hemoglobin value of all women in the experimental and control groups will be recorded as part of the hospital's routine procedure.

Study Type

Interventional

Enrollment (Actual)

146

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • None Selected
      • Malatya, None Selected, Turkey (Türkiye), 44000
        • Inonu University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Literate, No communication problems, Within the first 24 hours after birth, No psychiatric diagnosis, No health problems during pregnancy.

Exclusion Criteria:

illiterate in intensive care after birth

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: standard care
group without virtual glasses
Experimental: virtual glasses applied group
Virtual reality (VR) glasses are used as a midwifery intervention to reduce anxiety, stress, comfort and pain by drawing the individual's attention in a different direction. VR glasses are a stress induction method that provides a fictional reality simulation with visual-visual orientation and three-dimensional views that allow the person to experience real-time perspective. Women may experience pain at different levels in the postpartum period. Pain affects the woman's emotional state and severe pain can cause anxiety in the woman. Pain in the postpartum period is usually caused by rapid and intermittent contractions of the uterus. The application of pressure to the uterine fundus by the midwife to evaluate the amount of postpartum bleeding and the tone of the uterus may increase the woman's pain and anxiety level and may also cause deterioration in her general comfort. Considering this information, it is thought that the relaxing effect of using virtual glasses during the uterine ton

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale (VAS) scores
Time Frame: 20 minute
The Visual Analog Scale will be used to assess the pain that will occur during the postpartum uterine tone assessment. VAS is a scale created between 0-10 cm. According to the scale, 0 cm: pain is not severe at all, 10 cm: unbearable pain. On the scale, 0-44 mm indicates mild pain, 45-74 mm indicates moderate pain, and 75-100 mm indicates severe pain.
20 minute

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spielberger State Anxiety Inventory (STAI) Scores
Time Frame: 20 minute
The inventory, which was developed by Spielberger, Gorsuch and Lushene in 1970 and whose validity and reliability in Turkish were made by Öner and Le Compte in 1985, consists of 20 items measuring state anxiety. The State Anxiety Inventory (SAI) requires the individual to describe how he/she feels at a certain moment and under certain conditions. The inventory is answered using 4-point scales. The feelings and behaviors expressed in the State Anxiety Inventory items are indicated by selecting one of the options "(1) Not at all, (2) A little, (3) A lot and (4) Completely" according to the degree of severity of such experiences. There are 10 reverse items in the SAI. These are items 1, 2, 5, 8, 10, 11, 15, 16, 19 and 20. The remaining items 3, 4, 6, 7, 9, 12, 13, 14, 17, and 18 directly measure the expression. Two separate keys are prepared to determine the total weights of the direct and reverse items in scoring. The total weighted score obtained for the direct statements is subtracted
20 minute

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postpartum Comfort Scale (PPSC) Scores
Time Frame: 20 minute
The Postpartum Comfort Scale is a 5-point Likert-type scale developed by Karakaplan and Yıldız (2010) to measure comfort levels. Scoring and expressions ranging from "completely agree" (5 points) to "completely disagree" (1 point) were made for all scale items. The expression "completely agree" represents the highest comfort (5 points) in positive sentences, while it represents the lowest comfort (1 point) in negative sentences. In this case, the highest score that can be obtained from the scale is 170, and the lowest score is 34. An increase in the mean score obtained from the scale indicates that the comfort level has also increased. The Cronbach's Alpha reliability coefficient of the scale was found to be .78 for the total DSKÖ.
20 minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2024

Primary Completion (Actual)

February 1, 2025

Study Completion (Actual)

February 1, 2025

Study Registration Dates

First Submitted

April 16, 2026

First Submitted That Met QC Criteria

April 16, 2026

First Posted (Actual)

April 22, 2026

Study Record Updates

Last Update Posted (Actual)

April 22, 2026

Last Update Submitted That Met QC Criteria

April 16, 2026

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Research results will be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Related

Subscribe